Hospital Vall d’Hebron

Research here focuses on pulmonary arterial hypertension, a serious condition affecting the blood vessels in the lungs. The trials are designed to explore whether targeted supportive treatment can improve symptoms, functional capacity, and risk status while helping prevent clinical worsening.

• Studying pulmonary arterial hypertension in patients with idiopathic, hereditary, drug- and toxin-induced, and connective tissue disease-associated forms
• Evaluating vitamin D supplementation as a potential way to improve clinical outcomes and reduce worsening of disease

This work reflects a strong interest in better managing cardiopulmonary complications through more effective supportive care and outcome monitoring.

The Lupus Unit at Vall d’Hebron Institut de Recerca is conducting research in systemic lupus erythematosus, especially severe and treatment-resistant cases. These studies aim to assess new therapeutic options for improving disease control and safety in people with difficult-to-manage autoimmune disease.

• Investigating severe, refractory systemic lupus erythematosus in patients who need better treatment options
• Testing a new cell-based therapy to evaluate early signs of benefit and tolerability

The research highlights ongoing efforts to advance care for complex autoimmune diseases by finding approaches that may offer meaningful improvement where standard treatments are not enough.